Connect with us

Marijuana Movement

Andrew Yang Shares Startling Stats About Marijuana and Opioids Use

Brenda Loman



Andrew Yang Shares Startling Stats About Marijuana and Opioids Use
- Ad -

Andrew Yang recently commented on the difference in treatment that marijuana and opioids receive in the United States. Even though marijuana is classified as a schedule I drug, opioid prescriptions seem to be quite rampant.

Specifically, he tweeted,

This is not the first time that Yang has commented on the difference in treatment between marijuana and opioids. In October, Yang participated in a presidential debate in which he shared statistics and appeared to criticize the government on its inaction concerning the aggressive marketing of opioids by pharmaceutical companies, according to a report by Marijuana Moment.

According to a report by The Hill, Yang has previously indicated that he supports legalization of marijuana and the decriminalization of opioids in small amounts.

Brenda lives in Indiana and is a notorious book reader who grew to be an avid writer when it comes to all things health and food. While not reading and writing about a variety of wellness topics, she tends to her summer-long garden grooming. Having experienced the real-life benefits of CBD, she joined the team as a daily contributor while being a full-time mom to her three kids.

Continue Reading

Ultimate CBD Guide


ultimate-cbd-products-company-guidepopular-cbd-health-benefits best-cannabidiol-guide-resources hemp guide

TimesofCBD is the most active daily CBD news publication featuring the latest cannabis industry stories and marijuana market trends. As the leader in CBD-centric content curation, we invite all readers to come for the headlines and stay for the insights. Quality is the top priority when presenting user guides, analyzing product reviews and reporting fact-checked news announcements. All information is for educational and informational purposes only. Disclaimer.

Got news? Email

Copyright © 2020 | Latest CBD News, Cannabis Guides and Marijuana Trends
Note: Always seek real additional medical advice and consultation with a professional healthcare practitioner before considering any CBD. No statements found on this website have underwent Food and Drug Administration evaluation. The efficacy of any products or claims made have never been approved by the FDA either. No products shall ever be intended to diagnose, treat or cure any disease or prevent any ailment.